Australia's medicines regulator has issued a safety warning over the potential risk of suicidal thoughts and behaviours when taking Ozempic-style drugs.
The Therapeutic Goods Administration (TGA) released a safety alert on Monday, saying it had updated product warnings for GLP-1-based drugs to "ensure consistent information regarding the potential risk of suicidal thoughts or behaviours".
"The updates follow investigations by TGA and other international regulators," the alert said.
"Patients taking any of these medicines should tell their health professional if they experience new or worsening depression, suicidal thoughts or any unusual changes in mood or behaviour."
The TGA stressed there was not enough evidence to conclude the drugs caused those changes.
Read more- https://www.abc.net.au/news/2025-12-01/updated-warning-for-ozempic-mounjaro-glp-1-drugs/106087650



